Incidence and prevalence of acromegaly in a large US health plan database-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Incidence and prevalence of acromegaly in a large US health plan database

Published:2016-01-20 Issue:3 Volume:19 Page:262-267
ISSN:1386-341X
Container-title:Pituitary
language:en
Short-container-title:Pituitary

Author:

Burton Tanya,Le Nestour Elisabeth,Neary Maureen,Ludlam William H.

Funder

Novartis Pharmaceuticals Corporation

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s11102-015-0701-2.pdf

Reference13 articles.

1. Capatina C, Wass JA (2015) 60 Years of neuroendocrinology: acromegaly. J Endocrinol 226(2):T141–T160. doi: 10.1530/JOE-15-0109

2. Holdaway IM, Rajasoorya C (1999) Epidemiology of acromegaly. Pituitary 2:29–41

3. Scacchi M, Cavagnini F (2006) Acromegaly. Pituitary 9(4):297–303

4. Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R (1980) Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol (Oxf) 12(1):71–79

5. Bengtsson BA, Edén S, Ernest I, Odén A, Sjögren B (1988) Epidemiology and long-term survival in acromegaly. a study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand 223(4):327–335

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth hormone receptor antagonist pegvisomant and its role in the medical therapy of growth hormone excess;Best Practice & Research Clinical Endocrinology & Metabolism;2024-07

2. Acromegaly in humans and cats: Pathophysiological, clinical and management resemblances and differences;Growth Hormone & IGF Research;2024-06

3. The changing landscape of acromegaly – an epidemiological perspective;Reviews in Endocrine and Metabolic Disorders;2024-02-10

4. Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 2, specific diseases;Nature Reviews Endocrinology;2024-02-09

5. Acromegaly and Cancer: An Update;Archives of Medical Research;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3